Prognostic scales in dilated cardiomyopathy – Past, present, and future.

In the ever-evolving realm of contemporary medicine, the skill of accurate prognostication stands as an indispensable pillar, bearing equal weight with the essential arts of prompt clinical diagnosis and robust therapeutic intervention strategies. Across decades, cardiology has methodically crafted an array of prognostic tools, primarily addressing prevalent diseases such as coronary artery disease, atrial fibrillation, and heart failure (HF). Rooted in expansive multi-centre registries and randomized trials, each with their own specific inclusion and exclusion criteria, these models naturally vary in terms of study population, follow-up duration, and a range of clinical parameters, including age, sex, New York Heart Association (NYHA) class, ejection fraction (EF), and HF subtypes (preserved EF vs.
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research